Organic Cation Transporter 1 Inhibitors [MoA] - N0000191265

Pharmacologic Class Information

Pharmacologic Code N0000191265
Pharmacologic Name Organic Cation Transporter 1 Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Organic Cation Transporter 1 Inhibitors

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Organic Cation Transporter 1 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0227Lorbrena Non-Proprietary Name: LorlatinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0231Lorbrena Non-Proprietary Name: LorlatinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0251Xalkori Non-Proprietary Name: CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0507Xalkori Non-Proprietary Name: CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-1500Xalkori Non-Proprietary Name: CrizotinibCapsule, Coated PelletsOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8140Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8141Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
63539-927Lorbrena Non-Proprietary Name: LorlatinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
72482-100Vonjo Non-Proprietary Name: PacritinibCapsuleOralCti Biopharma Corp.ACTIVE